This program is intended for physicians and other healthcare professionals who care for patients with AL amyloidosis.
The goal of this activity is to improve the knowledge, competence, and performance of learners in using novel therapeutic options for patients with AL amyloidosis.
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.
Angela Dispenzieri, MD
Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine
Angela Dispenzieri, MD: consultant/advisor/speaker: Oncopeptides, Sorento; researcher: Alnylam, Bristol-Myers Squibb, Janssen, Pfizer, Takeda.
Anita D Souza, MD
Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Medical College of Wisconsin
Froedtert & Medical College of Wisconsin Cancer Center
Anita D’Souza, MD: consultant/advisor/speaker: Bristol-Myers Squibb, Janssen, Prothena; researcher: AbbVie, Caelum, Janssen, Prothena, Regeneron, Sanofi, Takeda, TeneoBio.
Jeffrey Zonder, MD
Professor of Oncology
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Jeffrey Zonder, MD: consultant/advisor/speaker: Caelum/AstraZeneca, Intellia, Janssen, Prothena, Regeneron, Takeda; researcher: Bristol-Myers Squibb.
Participation in this self-study activity should be completed in approximately 2.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from January 23, 2023, through January 22, 2024:
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation in this self-study activity should be completed in approximately 2.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 23, 2023, through January 22, 2024:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
This program has been made available online.